News & Insights
Do you ever wonder what our team is up to? Find out more by viewing our News, Articles, Insights & Blogs.
10 June 2025
Ascend Completes GMP Certification for Quality Control Testing in Munich Facility
Rockville, Maryland – 10 June 2025 – Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has received GMP certification...
Read More6 June 2025
Accelerating LVV Process Development with Fast, Precise Titer Determination – Part 3
Rapid LVV Titer Determination with the Virus Counter Plus Platform In Part One of this blog series, we introduced...
Read More2 June 2025
Accelerating LVV Process Development with Fast, Precise Titer Determination – Part 2
Overcoming the Limitations of Current LVV Titer Measurement As described in Part One of this blog series, quantification of...
Read More2 June 2025
Accelerating LVV Process Development with Fast, Precise Titer Determination – Part 1
Growing demand for lentiviral vectors (LVVs) is creating the need for robust, scalable, GMP manufacturing processes. Accelerating process development...
Read More5 March 2025
Ascend Advanced Therapies Appoints John Chiminski as Chair & Karen Flynn as Independent Director
Rockville, MD – March 5, 2025 – Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner,...
Read More3 February 2025
Polo-like kinase inhibitors increase AAV production by halting cell cycle progression
Recombinant adeno-associated viruses (rAAVs) are commonly used in gene therapy for preclinical research and therapeutic applications. Despite the clinical...
Read More1 February 2025
Recombinant AAV batch profiling by nanopore sequencing
Recombinant AAV vectors are widely used for in vivo gene therapy in all stages ranging from pre-clinical to clinical...
Read More12 December 2024
Enhancing AAV production with transcriptomics-informed pharmacology
Recombinant adeno-associated virus (rAAV) is a widely used viral vector for gene therapy. However, these vectors have limited availability...
Read More11 December 2024
Enhancing Quality Through Training
Ensuring the quality and safety of drug products is crucial and can only be achieved when all personnel involved...
Read More5 December 2024
Solving the AAV scalability challenge
Gene to GMP AAV manufacturing partner, Ascend, made a presentation at ESACT about leveraging technology to build a flexible...
Read More26 November 2024
The deep roots of gene therapy in Florida
Scientists have known about adeno-associated virus (AAV) for more than six decades. Researchers from around the world have been...
Read More12 November 2024
Ascend Advanced Therapies Partners with EW Healthcare Partners to Expand United States Capacity and Capabilities
London, United Kingdom – 12 November 2024 – Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with...
Read More